Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Daiichi Sankyo
Queensland Health
US Department of Justice

Generated: December 13, 2017

DrugPatentWatch Database Preview

FENTANYL-100 Drug Profile

« Back to Dashboard

Which patents cover Fentanyl-100, and what generic alternatives are available?

Fentanyl-100 is a drug marketed by 3m Drug Delivery, Actavis Labs Ut Inc, Aveva, Lavipharm Labs, Mallinckrodt Inc, Mayne Pharma, Mylan Technologies, and Noven. and is included in eight NDAs.

The generic ingredient in FENTANYL-100 is fentanyl. There are thirty-one drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the fentanyl profile page.
Drug patent expirations by year for FENTANYL-100

Pharmacology for FENTANYL-100

Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists

Medical Subject Heading (MeSH) Categories for FENTANYL-100

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
3m Drug DeliveryFENTANYL-100fentanylFILM, EXTENDED RELEASE;TRANSDERMAL202097-005Nov 4, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mylan TechnologiesFENTANYL-100fentanylFILM, EXTENDED RELEASE;TRANSDERMAL076258-004Jan 28, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Lavipharm LabsFENTANYL-100fentanylFILM, EXTENDED RELEASE;TRANSDERMAL077051-004Aug 4, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
NovenFENTANYL-100fentanylFILM, EXTENDED RELEASE;TRANSDERMAL077775-004Oct 16, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Actavis Labs Ut IncFENTANYL-100fentanylFILM, EXTENDED RELEASE;TRANSDERMAL076709-004Aug 20, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
AvevaFENTANYL-100fentanylFILM, EXTENDED RELEASE;TRANSDERMAL077449-004Oct 20, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mayne PharmaFENTANYL-100fentanylFILM, EXTENDED RELEASE;TRANSDERMAL077062-004Aug 20, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mallinckrodt IncFENTANYL-100fentanylFILM, EXTENDED RELEASE;TRANSDERMAL077154-004Feb 9, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Queensland Health
Express Scripts
Cantor Fitzgerald
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: